n South African Gastroenterology Review - Infliximab (Revellex) inflammatory bowel disease : guidelines

Volume 1, Issue 1
  • ISSN : 1812-1659



Extracted from text ... SAGES GUIDELINES The South African Gastroenterology Review - August 2003 18 Infliximab (Revellex) inflammatory bowel disease protein that is in the antibody. There is also a serious risk of re-activating pulmonary tuberculosis. The prognosis is very poor in these patients, especially when aggravated by HIV/ Aids. Guidelines for the use of Infliximab (Revellex) 1 The patient should be managed by a registered gastroenterologist. 2 The diagnosis of Crohn's Disease must be confirmed with recent small bowel enema, colonoscopy, histology and raised acute phase reactants. The exact combination of criteria would depend on the disease localization and the type of ..

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error